In addition, MerlinBiomedical COVID-19 antigen rapid test card approved CE certification!
Date：2022-04-01
CE2934 COVID Rapid Test card approved CE certification!
MerlinBiomedical COVID-19 Antigen rapid test card obtained EU CE certification on April 5, 2022
The "CE" mark is a safety certification mark that is regarded as a passport for manufacturers to open and enter the European market.
On March 11, 2022, the comprehensive team of the Joint Prevention and Control Mechanism of The State Council for the novel Coronavirus Pneumonia epidemic decided to supplement nucleic acid testing with antigen testing, and organized the formulation of the Application Plan for Novel Coronavirus Antigen Testing (Trial).
The novel coronavirus antigen test is conducted by combining antigen and antibody on the test strip, which is convenient and quick, and generally can produce results in 15-20 minutes. It can be used as an auxiliary diagnosis of novel coronavirus pneumonia. The company's novel coronavirus antigen self-test kit uses human nasopharyngeal swab and nasal swab samples to detect the protein of the virus itself by immunological methods, which can be detected in the early stage of viral infection.
